Therapeutic uses for Angiotensin-(1-7)

被引：27
|
作者：
Machado-Silva, Alice [1 ]
Passos-Silva, Danielle [2 ]
Santos, Robson Augusto [2 ]
Sinisterra, Ruben Dario [3 ]
机构：
[1] Fundacao Oswaldo Cruz, CDTS, Rio De Janeiro, Brazil
[2] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Fisiol & Biofis, Belo Horizonte, MG, Brazil
[3] Univ Fed Minas Gerais, Dept Quim, Inst Ciencias Exatas, Belo Horizonte, MG, Brazil
来源：
EXPERT OPINION ON THERAPEUTIC PATENTS | 2016年 / 26卷 / 06期
关键词：
Angiotensin (1-7); Arg0; Mas receptor; PanCyte; TXA-127; RAS; IMPROVES LIPID-METABOLISM; ORAL FORMULATION; SKELETAL-MUSCLE; ENZYME; MAS; SYSTEM; BRAIN; INFLAMMATION; INHIBITION; PEPTIDE;
D O I：
10.1080/13543776.2016.1179283
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Introduction: Angiotensin-(1-7) is a key component of the Renin-Angiotensin System, which can counter-regulate several deleterious effects caused by angiotensin II. Due to the potential for therapeutic use, several of its actions are specifically described in patents. Areas covered: In this review, the authors describe a plethora of therapeutic uses for Angiotensin-(1-7), claimed and supported by experimental evidence in patent documents and applications. Expert opinion: The clinical potential of Angiotensin-(1-7) as a therapeutic agent to treat several pathologies is evidenced by the variety of patents and clinical trials involving this peptide. Cancer treatment is one of the most advanced therapeutic areas, but clinical studies are also available in several other areas, such as cardiovascular, hematological, transplantation, surgical and medical procedures.
引用
收藏
页码：669 / 678
页数：10
相关论文
共 50 条
  • [31] Angiotensin-(1-7). One step forward?
    Buczko, W
    Kucharewicz, I
    POLISH JOURNAL OF PHARMACOLOGY, 2000, 52 (02): : 75 - 81
  • [32] Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodelling
    McKinney, Clare A.
    Fattah, Caroline
    Loughrey, Christopher M.
    Milligan, Graeme
    Nicklin, Stuart A.
    CLINICAL SCIENCE, 2014, 126 (11-12) : 815 - 827
  • [33] Angiotensin-(1-7)-Mediated Signaling in Cardiomyocytes
    Gomes, Eneas R. M.
    Santos, Robson A. S.
    Guatimosim, Silvia
    INTERNATIONAL JOURNAL OF HYPERTENSION, 2012, 2012
  • [34] CENTRAL AND PERIPHERAL ACTIONS OF ANGIOTENSIN-(1-7)
    SANTOS, RAS
    CAMPAGNOLESANTOS, MJ
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1994, 27 (04) : 1033 - 1047
  • [35] Megalin binds and internalizes angiotensin-(1-7)
    Gonzalez-Villalobos, RA
    Klassen, RB
    Allen, PL
    Johanson, K
    Baker, CB
    Kobori, H
    Hammond, TG
    Navar, LG
    HYPERTENSION, 2005, 46 (04) : 872 - 872
  • [36] Angiotensin-(1-7) as an antihypertensive, antifibrotic target
    Michael J. Katovich
    Justin L. Grobe
    Mohan K. Raizada
    Current Hypertension Reports, 2008, 10 : 227 - 232
  • [37] Modulation of the action of insulin by angiotensin-(1-7)
    Dominici, Fernando P.
    Burghi, Valeria
    Munoz, Marina C.
    Giani, Jorge F.
    CLINICAL SCIENCE, 2014, 126 (9-10) : 613 - 630
  • [38] Cardiac angiotensin-(1-7) in ischemic cardiomyopathy
    Averill, DB
    Ishiyama, Y
    Chappell, MC
    Ferrario, CM
    CIRCULATION, 2003, 108 (17) : 2141 - 2146
  • [39] Angiotensin-(1-7) and Its Effects in the Kidney
    Dilauro, Marc
    Burns, Kevin D.
    THESCIENTIFICWORLDJOURNAL, 2009, 9 : 522 - 535
  • [40] Vasopeptidase inhibition, omapatrilat and angiotensin-(1-7)
    Ferrario, C
    Smith, R
    Yunis, C
    Brosnihan, K
    Grim, C
    Campese, V
    Ruddy, M
    Vesterqvist, O
    Liao, W
    JOURNAL OF HYPERTENSION, 2000, 18 : S27 - S27
12345